Filipe Elvas

Antwerpen, VLG 2610, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Development and preclinical evaluation of selective vinyl sulfone-based probes for PET imaging of tumor-associated cathepsins.

Development and preclinical evaluation of selective vinyl sulfone-based probes for PET imaging of tumor-associated cathepsins.

Journal: EJNMMI radiopharmacy and chemistry

Published: June 22, 2026

IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting.

IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting.

Journal: Molecular therapy. Oncology

Published: May 08, 2026

Accurate Reference Region Calculation in Mouse Brain [18F]fallypride Studies.

Accurate Reference Region Calculation in Mouse Brain [18F]fallypride Studies.

Journal: Molecular imaging and biology

Published: December 01, 2025

Rodent biodistribution and dosimetry of the PET radioligands [18F]CHDI-385 and [18F]CHDI-386 targeting mutant huntingtin aggregates.

Rodent biodistribution and dosimetry of the PET radioligands [18F]CHDI-385 and [18F]CHDI-386 targeting mutant huntingtin aggregates.

Journal: Nuclear medicine and biology

Published: October 20, 2025

Structure-Property Investigation of New "KetoFAPI" Inhibitors of Fibroblast Activation Protein (FAP): Discovery of Highly Potent, Selective Compounds with Prolonged Residence Times and Promising Radiotheranostic Potential.

Structure-Property Investigation of New "KetoFAPI" Inhibitors of Fibroblast Activation Protein (FAP): Discovery of Highly Potent, Selective Compounds with Prolonged Residence Times and Promising Radiotheranostic Potential.

Journal: Journal of medicinal chemistry

Published: October 14, 2025

Targeted alpha therapy (r)evolution: emerging nuclides for clinical applications.

Targeted alpha therapy (r)evolution: emerging nuclides for clinical applications.

Journal: Trends in pharmacological sciences

Published: October 10, 2025

Correction to "Isoindolinone-Based PET Tracers for Imaging Mutant Huntingtin Aggregates".

Correction to "Isoindolinone-Based PET Tracers for Imaging Mutant Huntingtin Aggregates".

Journal: Journal of medicinal chemistry

Published: September 26, 2025

In vitro kinetic profiling by enzymatic approaches to select FAPIs with a long residence time.

In vitro kinetic profiling by enzymatic approaches to select FAPIs with a long residence time.

Journal: European journal of medicinal chemistry

Published: September 24, 2025

Synthesis and Preclinical Evaluation of Druglike 18F-Labeled Fibroblast Activation Protein (FAP) Inhibitors with Enhanced Tumor Retention.

Synthesis and Preclinical Evaluation of Druglike 18F-Labeled Fibroblast Activation Protein (FAP) Inhibitors with Enhanced Tumor Retention.

Journal: Bioconjugate chemistry

Published: August 12, 2025

Isoindolinone-Based PET Tracers for Imaging Mutant Huntingtin Aggregates.

Isoindolinone-Based PET Tracers for Imaging Mutant Huntingtin Aggregates.

Journal: Journal of medicinal chemistry

Published: July 07, 2025

In Vivo PET Imaging of [18F]CHDI-385, a Radioligand for Mutant Huntingtin Aggregates in a Mouse Model of Huntington Disease.

In Vivo PET Imaging of [18F]CHDI-385, a Radioligand for Mutant Huntingtin Aggregates in a Mouse Model of Huntington Disease.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: June 19, 2025

Preclinical validation and kinetic modelling of the SV2A PET ligand [18F]UCB-J in mice.

Preclinical validation and kinetic modelling of the SV2A PET ligand [18F]UCB-J in mice.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

Published: December 04, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026